본문 바로가기
KERD
논문KCI 등재

The Gut-Brain Axis: The Missing Link in Depression

1

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

The gut microbiota is essential to human health and the immune system and plays a major role in the bidirectional communication between the gut and the brain. Based on evidence, the gut microbiota is associated with metabolic disorders such as obesity, diabetes mellitus and neuropsychiatric disorders such as schizophrenia, autistic disorders, anxiety disorders and major depressive disorders. In the past few years, neuroscientific research has shown the importance of the microbiota in the development of brain systems. Recent studies showed that the microbiota could activate the immune and central nervous systems, including commensal and pathogenic microorganisms in the gastrointestinal tract. Gut microorganisms are capable of producing and delivering neuroactive substances such as serotonin and gamma-aminobutyric acid, which act on the gut-brain axis. Preclinical research in rodents suggested that certain probiotics have antidepressant and anxiolytic activities. Effects may be mediated via the immune system or neuroendocrine systems. Herein, we present the latest literature examining the effects of the gut microbiota on depression.

Abstract

The gut microbiota is essential to human health and the immune system and plays a major role in the bidirectional communication between the gut and the brain. Based on evidence, the gut microbiota is associated with metabolic disorders such as obesity, diabetes mellitus and neuropsychiatric disorders such as schizophrenia, autistic disorders, anxiety disorders and major depressive disorders. In the past few years, neuroscientific research has shown the importance of the microbiota in the development of brain systems. Recent studies showed that the microbiota could activate the immune and central nervous systems, including commensal and pathogenic microorganisms in the gastrointestinal tract. Gut microorganisms are capable of producing and delivering neuroactive substances such as serotonin and gamma-aminobutyric acid, which act on the gut-brain axis. Preclinical research in rodents suggested that certain probiotics have antidepressant and anxiolytic activities. Effects may be mediated via the immune system or neuroendocrine systems. Herein, we present the latest literature examining the effects of the gut microbiota on depression.

참고문헌 (74)

  1. Khanna S., "A clinician's primer on the role of the microbiome in human health and disease", Mayo Clin Proc, 89, pp.107~114 (2014)
  2. Borre YE., "Microbiota and neurodevelopmental windows : implications for brain disorders", Trends Mol Med, 20, pp.509~518 (2014)
  3. de Vos WM., "Role of the intestinal microbiome in health and disease : from correlation to causation. Nutr Rev, 70 Suppl 1", S45-S56 (2012)
  4. Lozupone CA., "Diversity, stability and resilience of the human gut microbiota", Nature, 489, pp.220~230 (2012)
  5. Jumpstart Consortium Human Microbiome Project Data Generation Working Group., "Evaluation of 16S rDNA-based community profiling for human microbiome research", PLoS One, 7, pp.e39315~ (2012)
  6. Reardon S., "Gut-brain link grabs neuroscientists", Nature, 515, pp.175~177 (2014)
  7. Flint HJ., "The impact of nutrition on the human microbiome", Nutr Rev, 70(Suppl 1), pp.S10~S13 (2012)
  8. Brandt LJ., "American Journal of Gastroenterology Lecture : Intestinal microbiota and the role of fecal microbiota transplant(FMT)in treatment of C. difficile infection", Am J Gastroenterol, 108, pp.177~185 (2013)
  9. O'Mahony L., "Lactobacillus and bifidobacterium in irritable bowel syndrome : symptom responses and relationship to cytokine profiles", Gastroenterology, 128, pp.541~551 (2005)
  10. Tosh PK., "Infection control in the multidrugresistant era : tending the human microbiome", Clin Infect Dis, 54, pp.707~713 (2012)
  11. Martínez I., "Gut microbiome composition is linked to whole grain-induced immunological improvements", ISME J, 7, pp.269~280 (2013)
  12. Bäckhed F., "Mechanisms underlying the resistance to diet-induced obesity in germ-free mice", Proc Natl Acad Sci U S A, 104, pp.979~984 (2007)
  13. Hornig M., "The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness", Curr Opin Rheumatol, 25, pp.488~795 (2013)
  14. Strachan DP., "Hay fever, hygiene, and household size", BMJ, 299, pp.1259~1260 (1989)
  15. Rook GA., "Innate immune responses to mycobacteria and the downregulation of atopic responses", Curr Opin Allergy Clin Immunol, 3, pp.337~342 (2003)
  16. Rook GA., "99th Dahlem conference on infection, inflammation and chronic inflammatory disorders : darwinian medicine and the 'hygiene' or 'old friends' hypothesis", Clin Exp Immunol, 160, pp.70~79 (2010)
  17. Rook GA., "Hygiene and other early childhood influences on the subsequent function of the immune system", Brain Res, 1617, pp.47~62 (2015)
  18. Barrett E., "γ-Aminobutyric acid production by culturable bacteria from the human intestine", J Appl Microbiol, 113, pp.411~417 (2012)
  19. Lyte M., "Probiotics function mechanistically as delivery vehicles for neuroactive compounds : Microbial endocrinology in the design and use of probiotics", Bioessays, 33, pp.574~581 (2011)
  20. Desbonnet L., "The probiotic Bifidobacteria infantis : An assessment of potential antidepressant properties in the rat", J Psychiatr Res, 43, pp.164~174 (2008)
  21. Muccioli GG., "The endocannabinoid system links gut microbiota to adipogenesis", Mol Syst Biol, 6, pp.392~ (2010)
  22. Collins SM., "The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease", Gastroenterology, 136, pp.2003~2014 (2009)
  23. Davey KJ., "Gender-dependent consequences of chronic olanzapine in the rat : effects on body weight, inflammatory, metabolic and microbiota parameters", Psychopharmacology(Berl), 221, pp.155~169 (2012)
  24. Bailey MT., "Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys", Dev Psychobiol, 35, pp.146~155 (1999)
  25. O'Mahony SM., "Early life stress alters behavior, immunity, and microbiota in rats : implications for irritable bowel syndrome and psychiatric illnesses", Biol Psychiatry, 65, pp.263~267 (2009)
  26. Round JL., "Coordination of tolerogenic immune responses by the commensal microbiota", J Autoimmun, 34, pp.J220~J225 (2010)
  27. Olszak T., "Microbial exposure during early life has persistent effects on natural killer T cell function", Science, 336, pp.489~493 (2012)
  28. Neish AS., "Microbes in gastrointestinal health and disease", Gastroenterology, 136, pp.65~80 (2009)
  29. Dinan TG., "Probiotics in the treatment of depression : science or science fiction?", Aust N Z J Psychiatry, 45, pp.1023~1025 (2011)
  30. Carvalho FA., "Toll-like receptor-gut microbiota interactions : perturb at your own risk", Annu Rev Physiol, 74, pp.177~198 (2012)
  31. Lucas K., "Role of the Toll Like receptor(TLR)radical cycle in chronic inflammation : possible treatments targeting the TLR4 pathway", Mol Neurobiol, 48, pp.190~204 (2013)
  32. Takeuchi O., "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)
  33. McKernan DP., "Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype", Transl Psychiatry, 1, pp.e36~ (2011)
  34. McCusker RH., "Immune-neural connections : how the immune system's response to infectious agents influences behavior", J Exp Biol, 216, pp.84~98 (2013)
  35. Udina M., "Interferon-induced depression in chronic hepatitis C : a systematic review and meta-analysis", J Clin Psychiatry, 73, pp.1128~1138 (2012)
  36. McNutt MD., "Neurobehavioral effects of interferon-α in patients with hepatitis-C : symptom dimensions and responsiveness to paroxetine", Neuropsychopharmacology, 37, pp.1444~1454 (2012)
  37. Min Ma, "Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration", Clinical Psychopharmacology and Neuroscience, 12(1), pp.31~36 (2014), 대한정신약물학회
  38. Maes M., "The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway", Int Immunopharmacol, 5, pp.609~618 (2005)
  39. Levkovich T., "Probiotic bacteria induce a 'glow of health'", PLoS One, 8, pp.e53867~ (2013)
  40. Macpherson AJ., "Gut flora--mechanisms of regulation", Eur J Surg Suppl, (587), pp.53~57 (2002)
  41. Kopp MV., "Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates", Clin Exp Allergy, 38, pp.602~610 (2008)
  42. Costello EK., "The application of ecological theory toward an understanding of the human microbiome", Science, 336, pp.1255~1262 (2012)
  43. Fetissov SO., "The new link between gut-brain axis and neuropsychiatric disorders", Curr Opin Clin Nutr Metab Care, 14, pp.477~482 (2011)
  44. Ait-Belgnaoui A., "Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats", Psychoneuroendocrinology, 37, pp.1885~1895 (2012)
  45. Smythies LE., "Microbiota, the immune system, black moods and the brain-melancholia updated", Front Hum Neurosci, 8, pp.720~ (2014)
  46. Severance EG., "Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia", Schizophr Res, 148, pp.130~137 (2013)
  47. O'Mahony SM., "Serotonin, tryptophan metabolism and the brain-gutmicrobiome axis", Behav Brain Res, 277, pp.32~48 (2015)
  48. Wren AM., "Gut hormones and appetite control", Gastroenterology, 132, pp.2116~2130 (2007)
  49. Macfarlane S., "Regulation of short-chain fatty acid production", Proc Nutr Soc, 62, pp.67~72 (2003)
  50. Macfabe DF., "Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders", Microb Ecol Health Dis, 23 (2012)[DOI]
  51. Kimura I., "The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43", Nat Commun, 4, pp.1829~ (2013)
  52. Wang X., "Evidences for vagus nerve in maintenance of immune balance and transmission of immune information from gut to brain in STM-infected rats", World J Gastroenterol, 8, pp.540~545 (2002)
  53. Borovikova LV., "Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin", Nature, 405, pp.458~462 (2000)
  54. Perez-Burgos A., "Psychoactive bacteria Lactobacillus rhamnosus(JB-1)elicits rapid frequency facilitation in vagal afferents", Am J Physiol Gastrointest Liver Physiol, 304, pp.G211~G220 (2013)
  55. Diaz Heijtz R., "Normal gut microbiota modulates brain development and behavior", Proc Natl Acad Sci U S A, 108, pp.3047~3052 (2011)
  56. Douglas-Escobar M., "Effect of intestinal microbial ecology on the developing brain", JAMA Pediatr, 167, pp.374~379 (2013)
  57. Lyte M., "Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation", Physiol Behav, 65, pp.63~68 (1998)
  58. Desbonnet L., "Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression", Neuroscience, 170, pp.1179~1188 (2010)
  59. Dinan TG., "Psychobiotics : a novel class of psychotropic", Biol Psychiatry, 74, pp.720~726 (2013)
  60. Neufeld KA., "Effects of intestinal microbiota on anxiety-like behavior", Commun Integr Biol, 4, pp.492~494 (2011)
  61. Clarke G., "The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner", Mol Psychiatry, 18, pp.666~673 (2013)
  62. Messaoudi M., "Assessment of psychotropic-like properties of a probiotic formulation(Lactobacillus helveticus R0052 and Bifidobacterium longum R0175)in rats and human subjects", Br J Nutr, 105, pp.755~764 (2011)
  63. Messaoudi M., "Beneficial psychological effects of a probiotic formulation(Lactobacillus helveticus R0052 and Bifidobacterium longum R0175)in healthy human volunteers", Gut Microbes, 2, pp.256~261 (2011)
  64. Bravo JA., "Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve", Proc Natl Acad Sci U S A, 108, pp.16050~16055 (2011)
  65. Ohland CL., "Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome", Psychoneuroendocrinology, 38, pp.1738~1747 (2013)
  66. Naseribafrouei A., "Correlation between the human fecal microbiota and depression", Neurogastroenterol Motil, 26, pp.1155~1162 (2014)
  67. Tillisch K., "Consumption of fermented milk product with probiotic modulates brain activity", Gastroenterology, 144, pp.1394~1401 (2013)
  68. Berk M., "So depression is an inflammatory disease, but where does the inflammation come from?", BMC Med, 11, pp.200~ (2013)
  69. Dash S., "The gut microbiome and diet in psychiatry : focus on depression", Curr Opin Psychiatry, 28, pp.1~6 (2015)
  70. Phillips JGP., "The treatment of melancholia by the lactic acid bacillus", Br J Psychiatry, 56, pp.422~431 (1910)
  71. Vanderhoof JA., "Probiotics in the United States", Clin Infect Dis, 46(Suppl 2), pp.S67~S72 (2008)
  72. Fond G., "The"psychomicrobiotic" : Targeting microbiota in major psychiatric disorders : a systematic review", Pathol Biol(Paris), 63, pp.35~42 (2015)
  73. Smits LP., "Therapeutic potential of fecal microbiota transplantation", Gastroenterology, 145, pp.946~953 (2013)
  74. Evrensel A., "Gut-brain axis : the role of gut microbiota in the psychiatric disorders", Curr Approach Psychiatry, 7, pp.461~472 (2015)

관련 논문AI추천

이 간행물의 다른 논문 (16건)